No Data
No Data
Mangoceuticals Raises Capital and Boosts CEO Perks
Mangoceuticals Second Quarter 2024 Earnings: US$0.092 Loss per Share (Vs US$0.14 Loss in 2Q 2023)
Mangoceuticals Files to Sell 16.17M Shares of Common Stock for Holders
Mangoceuticals Reports 1H Results
Express News | Mangoceuticals On Aug. 14 Reported Quarter Ended June 30 EPS $(0.09) Up From $(0.14) YoY; Revenue $163,163 Up From $141,237 YoY
Express News | Mangoceuticals H1 Shareholder Equity Increased To $13.829M Vs $7774.754K YoY
No Data
No Data